MeSH term
Frequency | Condition_Probility | Aged | 4 | 0.0 |
Humans | 91 | 0.0 |
Time Factors | 3 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Mutation | 14 | 0.0 |
RNA, Neoplasm/biosynthesis | 2 | 1.0 |
Research Support, Non-U.S. Gov't | 63 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 14 | 0.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 8 | 0.0 |
Hela Cells | 14 | 0.0 |
Leucine Zippers | 5 | 3.0 |
Open Reading Frames | 2 | 0.0 |
Protein Transport | 7 | 1.0 |
Transcription Factors/*metabolism | 8 | 0.0 |
Transfection | 15 | 0.0 |
Ubiquitin/*metabolism | 8 | 4.0 |
Zinc Fingers | 2 | 0.0 |
Amino Acid Sequence | 22 | 0.0 |
Animals | 27 | 0.0 |
Binding Sites | 5 | 0.0 |
Models, Molecular | 6 | 0.0 |
Molecular Sequence Data | 29 | 0.0 |
Protein Conformation | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 32 | 0.0 |
Saccharomyces cerevisiae/metabolism | 2 | 1.0 |
Sequence Alignment | 3 | 0.0 |
Ubiquitin/metabolism | 7 | 3.0 |
*Adenosinetriphosphatase | 4 | 5.0 |
DNA-Binding Proteins/metabolism | 8 | 0.0 |
*Saccharomyces cerevisiae Proteins | 9 | 0.0 |
Transcription Factors/metabolism | 8 | 0.0 |
Cell Line | 23 | 0.0 |
DNA, Complementary/metabolism | 4 | 0.0 |
DNA-Binding Proteins/chemistry/*physiology | 2 | 6.0 |
Down-Regulation | 5 | 0.0 |
Mice | 12 | 0.0 |
Precipitin Tests | 5 | 0.0 |
Protein Binding | 13 | 0.0 |
Retinoblastoma Protein/metabolism | 2 | 0.0 |
Transcription Factors/chemistry/*physiology | 2 | 5.0 |
Two-Hybrid System Techniques | 12 | 1.0 |
Endosomes/*metabolism | 7 | 6.0 |
Epidermal Growth Factor/metabolism | 2 | 0.0 |
Ligases/*metabolism | 2 | 2.0 |
Protein Transport/physiology | 3 | 2.0 |
Receptor, Epidermal Growth Factor/metabolism | 3 | 0.0 |
*Vesicular Transport Proteins | 6 | 3.0 |
Blotting, Western | 6 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 7 | 0.0 |
Female | 20 | 0.0 |
Protein p53/*metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 7 | 0.0 |
Tumor Cells, Cultured | 17 | 0.0 |
Amino Acid Motifs | 13 | 1.0 |
DNA-Binding Proteins/chemistry/*genetics/*physiology | 2 | 40.0 |
Gene Expression | 4 | 0.0 |
Microscopy, Electron | 5 | 0.0 |
Protein Structure, Tertiary | 10 | 0.0 |
Transcription Factors/chemistry/*genetics/*physiology | 2 | 33.0 |
Virus Replication | 7 | 0.0 |
HIV-1/*physiology | 7 | 1.0 |
Cell Compartmentation | 2 | 0.0 |
Cell Membrane/metabolism | 4 | 0.0 |
Endosomes/metabolism | 4 | 3.0 |
Gene Products, gag/genetics/*metabolism | 5 | 50.0 |
*Virus Assembly | 3 | 12.0 |
Fungal Proteins/*metabolism | 2 | 2.0 |
Gene Products, gag/chemistry/metabolism | 2 | 100.0 |
Protein Transport/*physiology | 2 | 4.0 |
Recombinant Fusion Proteins/genetics/metabolism | 4 | 0.0 |
Surface Plasmon Resonance | 2 | 1.0 |
COS Cells | 5 | 0.0 |
HIV-1/genetics/*metabolism | 3 | 4.0 |
Ubiquitin-Conjugating Enzymes | 5 | 10.0 |
3T3 Cells | 3 | 0.0 |
Ligases/metabolism | 2 | 3.0 |
*Nuclear Proteins | 2 | 0.0 |
Ubiquitins/metabolism | 2 | 1.0 |
Base Sequence | 12 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Comparative Study | 9 | 0.0 |
Endocytosis/*physiology | 2 | 1.0 |
Gene Library | 3 | 0.0 |
Gene Products, gag/metabolism | 3 | 23.0 |
Plasmids/genetics | 3 | 0.0 |
RNA, Small Interfering/genetics | 2 | 1.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Leucine Zippers/*genetics | 2 | 9.0 |
Sequence Deletion | 4 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 3 | 0.0 |
Lysosomes/metabolism | 2 | 1.0 |
Saccharomyces cerevisiae Proteins/genetics | 2 | 5.0 |
Species Specificity | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 3 | 0.0 |
Cell Transformation, Neoplastic/*genetics | 3 | 1.0 |
DNA-Binding Proteins/*genetics | 15 | 0.0 |
Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Transcription Factors/*genetics | 15 | 0.0 |
Transcription, Genetic | 10 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 4 | 2.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Transcription Factors/chemistry/genetics/*metabolism | 4 | 2.0 |
Acute Disease | 2 | 0.0 |
Loss of Heterozygosity | 2 | 0.0 |
Phosphoric Monoester Hydrolases/*genetics | 4 | 1.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
*Tumor Suppressor Proteins | 5 | 0.0 |
Blotting, Southern | 8 | 0.0 |
Carcinoma, Hepatocellular/*genetics | 2 | 2.0 |
DNA Mutational Analysis | 4 | 0.0 |
Genes, Tumor Suppressor/*genetics | 10 | 3.0 |
Liver Neoplasms/*genetics | 2 | 1.0 |
*Loss of Heterozygosity | 2 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
Neoplasm Proteins/*genetics | 4 | 0.0 |
Blotting, Northern | 7 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
*Transcription, Genetic | 7 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Neoplasm Invasiveness | 2 | 0.0 |
*Acid Anhydride Hydrolases | 4 | 1.0 |
Adult | 5 | 0.0 |
DNA/analysis | 2 | 0.0 |
*Neoplasm Proteins | 4 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Chromosomes, Human, Pair 11 | 3 | 0.0 |
*Genes, Tumor Suppressor | 4 | 0.0 |
Gene Products, gag/*metabolism | 3 | 23.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Disease Progression | 3 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 2 | 0.0 |
Neoplasm Proteins/genetics | 3 | 0.0 |
*RNA Splicing | 4 | 1.0 |
DNA, Neoplasm/genetics | 3 | 0.0 |
Chromosomes, Human, Pair 11/genetics | 3 | 1.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Organ Specificity | 2 | 0.0 |
RNA Splicing | 5 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Virion/*metabolism | 3 | 14.0 |
Breast Neoplasms/*genetics | 4 | 0.0 |
Gene Deletion | 6 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Neoplasm Metastasis | 2 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
*Adaptor Proteins, Vesicular Transport | 2 | 0.0 |
Binding Sites/genetics | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
Neoplasms/*genetics | 2 | 0.0 |
Point Mutation | 3 | 0.0 |
Genetic Markers | 2 | 0.0 |
Virion/physiology | 2 | 8.0 |
Catalysis | 2 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Breast/chemistry | 2 | 9.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
Ubiquitins/*metabolism | 2 | 1.0 |
Hamsters | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Plasmids/metabolism | 4 | 0.0 |
Carrier Proteins/genetics/*metabolism | 2 | 0.0 |
Protein Binding/physiology | 2 | 0.0 |
RNA Interference | 2 | 0.0 |
DNA-Binding Proteins/*chemistry/metabolism | 2 | 2.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Transcription Factors/*chemistry/metabolism | 2 | 4.0 |
Genes, Dominant | 3 | 0.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Virion/metabolism | 3 | 7.0 |
Virus Assembly | 3 | 11.0 |
Models, Biological | 2 | 0.0 |
Phosphoproteins/genetics | 2 | 1.0 |
Microscopy, Confocal | 3 | 0.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Virus Shedding/*physiology | 2 | 50.0 |
*Ubiquitin-Protein Ligases | 2 | 0.0 |
